本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

MBX Biosciences

14.57
+1.5411.82%
盘后14.700.1300+0.89%19:30 EDT
成交量:93.67万
成交额:1,379.75万
市值:4.87亿
市盈率:-3.71
高:15.92
开:12.91
低:12.33
收:13.03
数据加载中...
2025/06/16

重要事件披露

Form 8-K - Current report
2025/06/09

重要事件披露

Form 8-K - Current report
2025/06/06

重要事件披露

Form 8-K - Current report
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/04/07

重要事件披露

Form 8-K - Current report
2025/03/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors